Zhejiang Yatai Pharmaceutical Co., Ltd. (SHE:002370)
China · Delayed Price · Currency is CNY 7.39
-0.24 (-3.15%)
Apr 9, 2026, 3:04 PM CST
SHE:002370 Revenue
Zhejiang Yatai Pharmaceutical had revenue of 76.23M CNY in the quarter ending September 30, 2025, a decrease of -10.21%. This brings the company's revenue in the last twelve months to 326.64M, down -23.25% year-over-year. In the year 2024, Zhejiang Yatai Pharmaceutical had annual revenue of 405.17M, down -3.68%.
Revenue (ttm)
326.64M
Revenue Growth
-23.25%
P/S Ratio
16.87
Revenue / Employee
617.48K
Employees
529
Market Cap
5.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 405.17M | -15.47M | -3.68% |
| Dec 31, 2023 | 420.64M | 47.20M | 12.64% |
| Jan 1, 2023 | 373.44M | 58.31M | 18.50% |
| Jan 1, 2022 | 315.13M | -199.75M | -38.80% |
| Dec 31, 2020 | 514.89M | -193.10M | -27.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jianmin Pharmaceutical Group | 3.37B |
| Jinling Pharmaceutical Company | 3.20B |
| Luoxin Pharmaceuticals Group Stock | 2.49B |
| Tianjin Lisheng Pharmaceutical | 1.39B |
| Beijing Beilu Pharmaceutical | 1.13B |
| Teyi Pharmaceutical Group Co.,Ltd | 924.53M |
| Chongqing Pharscin Pharmaceutical | 786.51M |
| ChengDu ShengNuo Biotec | 741.34M |